122 related articles for article (PubMed ID: 31039838)
1. Sorafenib-Loaded Ligand-Functionalized Polymer-Lipid Hybrid Nanoparticles for Enhanced Therapeutic Effect Against Liver Cancer.
Tang S; Li Y
J Nanosci Nanotechnol; 2019 Nov; 19(11):6866-6871. PubMed ID: 31039838
[TBL] [Abstract][Full Text] [Related]
2. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles.
Wang H; Sun S; Zhang Y; Wang J; Zhang S; Yao X; Chen L; Gao Z; Xie B
Drug Deliv; 2019 Dec; 26(1):89-97. PubMed ID: 30744448
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
4. Anti-GPC3 Antibody Tagged Cationic Switchable Lipid-Based Nanoparticles for the Co-Delivery of Anti-miRNA27a And Sorafenib in Liver Cancers.
Wang Z; Zhao K; Zhang Y; Duan X; Zhao Y
Pharm Res; 2019 Aug; 36(10):145. PubMed ID: 31396764
[TBL] [Abstract][Full Text] [Related]
5. Low density lipoprotein receptor (LDLR)-targeted lipid nanoparticles for the delivery of sorafenib and Dihydroartemisinin in liver cancers.
Wang Z; Duan X; Lv Y; Zhao Y
Life Sci; 2019 Dec; 239():117013. PubMed ID: 31678287
[TBL] [Abstract][Full Text] [Related]
6. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin-loaded folic acid-conjugated lipid nanoparticles for enhanced therapeutic efficacy in ovarian cancers.
Lv L; Zhuang YX; Zhang HW; Tian NN; Dang WZ; Wu SY
Biomed Pharmacother; 2017 Jul; 91():999-1005. PubMed ID: 28525949
[TBL] [Abstract][Full Text] [Related]
8. Heparin-functionalized Pluronic nanoparticles to enhance the antitumor efficacy of sorafenib in gastric cancers.
Yang YC; Cai J; Yin J; Zhang J; Wang KL; Zhang ZT
Carbohydr Polym; 2016 Jan; 136():782-90. PubMed ID: 26572413
[TBL] [Abstract][Full Text] [Related]
9. miR-542-3p Appended Sorafenib/All-trans Retinoic Acid (ATRA)-Loaded Lipid Nanoparticles to Enhance the Anticancer Efficacy in Gastric Cancers.
Li T; Zhang Y; Meng YP; Bo LS; Ke WB
Pharm Res; 2017 Dec; 34(12):2710-2719. PubMed ID: 29181687
[TBL] [Abstract][Full Text] [Related]
10. Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics.
Li YJ; Dong M; Kong FM; Zhou JP
Int J Pharm; 2015 Jul; 489(1-2):83-90. PubMed ID: 25888801
[TBL] [Abstract][Full Text] [Related]
11. Design, In Silico Modelling, and Functionality Theory of Novel Folate Receptor Targeted Rutin Encapsulated Folic Acid Conjugated Keratin Nanoparticles for Effective Cancer Treatment.
Kunjiappan S; Panneerselvam T; Govindaraj S; Parasuraman P; Baskararaj S; Sankaranarayanan M; Arunachalam S; Babkiewicz E; Jeyakumar A; Lakshmanan M
Anticancer Agents Med Chem; 2019; 19(16):1966-1982. PubMed ID: 31267878
[TBL] [Abstract][Full Text] [Related]
12. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy.
Khan MM; Madni A; Filipczak N; Pan J; Rehman M; Rai N; Attia SA; Torchilin VP
Nanomedicine; 2020 Aug; 28():102228. PubMed ID: 32485321
[TBL] [Abstract][Full Text] [Related]
13. Release of a liver anticancer drug, sorafenib from its PVA/LDH- and PEG/LDH-coated iron oxide nanoparticles for drug delivery applications.
Ebadi M; Bullo S; Buskara K; Hussein MZ; Fakurazi S; Pastorin G
Sci Rep; 2020 Dec; 10(1):21521. PubMed ID: 33298980
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Wang T; Zhang J; Hou T; Yin X; Zhang N
Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
[TBL] [Abstract][Full Text] [Related]
16. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer.
Shukla SK; Kulkarni NS; Farrales P; Kanabar DD; Parvathaneni V; Kunda NK; Muth A; Gupta V
Pharm Res; 2020 Mar; 37(3):67. PubMed ID: 32166411
[TBL] [Abstract][Full Text] [Related]
18. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates.
Choudhury H; Pandey M; Wen LP; Cien LK; Xin H; Yee ANJ; Lee NJ; Gorain B; Amin MCIM; Pichika MR
Curr Pharm Des; 2020; 26(42):5365-5379. PubMed ID: 32693762
[TBL] [Abstract][Full Text] [Related]
19. Folate Receptor-targeted Bioflavonoid Genistein-loaded Chitosan Nanoparticles for Enhanced Anticancer Effect in Cervical Cancers.
Cai L; Yu R; Hao X; Ding X
Nanoscale Res Lett; 2017 Aug; 12(1):509. PubMed ID: 28853026
[TBL] [Abstract][Full Text] [Related]
20. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
